Minimal engraftment of human CD34+ cells mobilized from healthy donors in the infarcted heart of athymic nude rats

Stem Cells and Development

Volumn 18, Issue 6, 2009, Pages 845-855

  Sondergaard, Claus S ^a,c   Bonde, Jesper ^b   Dagnæs Hansen, Frederik ^c   Nielsen, Jan M ^a   Zachar, Vladimir ^d   Holm, Mette ^a   Hokland, Peter ^a   Pedersen, Lene ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD34 SELECTION; CELL KINETICS; CONTROLLED STUDY; DONOR; ENGRAFTMENT; FUNCTIONAL ASSESSMENT; HEMATOPOIESIS; IMMUNOFLUORESCENCE TEST; NONHUMAN; NUDE RAT; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RAT; SCID MOUSE; STEM CELL MOBILIZATION; XENOGRAFT;

ANIMALS; ANTIGENS, CD34; ANTIGENS, CD45; FLOW CYTOMETRY; FLUORESCENCE; HEALTH; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KINETICS; MICE; MICE, SCID; MYOCARDIAL INFARCTION; RATS; RATS, NUDE; TIME FACTORS; TISSUE DONORS; VENTRICULAR FUNCTION, LEFT;

ANIMALIA; MUS; RATTUS;

EID: 67651087202     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0006     Document Type: Article

References (35)

1. Dimmeler S, AM Zeiher and MD Schneider. (2005). Unchain my heart: the scientif c foundations of cardiac repair. J Clin Invest 115:572-583.
2. Sharma R and R Raghubir. (2007). Stem cell therapy: a hope for dying hearts. Stem Cells Dev 16:517-536.
3. Uchida N and IL Weissman. (1992). Searching for hematopoi-etic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Exp Med 175:175-184.
4. Orlic D, J Kajstura, S Chimenti, I Jakoniuk, SM Anderson, B Li, J Pickel, R McKay, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705.
5. Orlic D, J Kajstura, S Chimenti, F Limana, I Jakoniuk, F Quaini, B Nadal-Ginard, DM Bodine, A Leri and P Anversa. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98:10344-10349.
6. Nygren JM, S Jovinge, M Breitbach, P Sawen, W Roll, J Hescheler, J Taneera, BK Fleischmann and SE Jacobsen. (2004). Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10:494-501.
7. Murry CE, MH Soonpaa, H Reinecke, H Nakajima, HO Nakajima, M Rubart, KB Pasumarthi, JI Virag, SH Bartelmez, V Poppa, G Bradford, JD Dowell, DA Williams and LJ Field. (2004). Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668.
8. Balsam LB, AJ Wagers, JL Christensen, T Kof dis, IL Weissman and RC Robbins. (2004). Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673.
9. Asahara T, T Murohara, A Sullivan, M Silver, R van der Zee, T Li, B Witzenbichler, G Schatteman and JM Isner. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
10. Dao MA, J Arevalo and JA Nolta. (2003). Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 101:112-118.
11. Hess DA, TE Meyerrose, L Wirthlin, TP Craft, PE Herrbrich, MH Creer and JA Nolta. (2004). Functional characterization of highly purif ed human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104:1648-1655.
12. Yin AH, S Miraglia, ED Zanjani, G Almeida-Porada, M Ogawa, AG Leary, J Olweus, J Kearney and DW Buck. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012.
13. Kocher AA, MD Schuster, MJ Szabolcs, S Takuma, D Burkhoff, J Wang, S Homma, NM Edwards and S Itescu. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apopto-sis, reduces remodeling and improves cardiac function. Nat Med 7:430-436.
14. Yeh ET, S Zhang, HD Wu, M Korbling, JT Willerson and Z Estrov. (2003). Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108:2070-2073.
15. Schnell SA, WA Staines and MW Wessendorf. (1999). Reduction of lipofuscin-like autof uorescence in f uorescently labeled tissue. J Histochem Cytochem 47:719-730.
16. Hogan CJ, EJ Shpall, I McNiece and G Keller. (1997). Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells. Biol Blood Marrow Transplant 3:236-246.
17. van der Loo JC, H Hanenberg, RJ Cooper, FY Luo, EN Lazaridis and DA Williams. (1998). Nonobese diabetic/severe combined immunodef ciency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood 92:2556-2570.
18. Rolstad B. (2001). The athymic nude rat: an animal experimental model to reveal novel aspects of innate immune responses? Immunol Rev 184:136-144.
19. Ayach BB, M Yoshimitsu, F Dawood, M Sun, S Arab, M Chen, K Higuchi, C Siatskas, P Lee, H Lim, J Zhang, E Cukerman, WL Stanford, JA Medin and PP Liu. (2006). Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. Proc Natl Acad Sci USA 103:2304-2309.
20. Lin Y, M Vandeputte and M Waer. (1997). Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 158:5658-5667.
21. Grinnemo KH, A Mansson-Broberg, K Leblanc, M Corbascio, E Wardell, AJ Siddiqui, X Hao, C Sylven and G Dellgren. (2006). Human mesenchymal stem cells do not differentiate into cardio-myocytes in a cardiac ischemic xenomodel. Ann Med 38:144-153.
22. Agbulut O, S Vandervelde, N Al Attar, J Larghero, S Ghostine, B Leobon, E Robidel, P Borsani, M Le Lorc'h, A Bissery, C Chomienne, P Bruneval, JP Marolleau, JT Vilquin, A Hagege, JL Samuel and P Menasche. (2004). Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol 44:458-463.
23. Kocher AA, MD Schuster, N Bonaros, K Lietz, G Xiang, TP Martens, PA Kurlansky, H Sondermeijer, P Witkowski, A Boyle, S Homma, SF Wang and S Itescu. (2006). Myocardial homing and neovas-cularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 40:455-464.
24. Schuster MD, AA Kocher, T Seki, TP Martens, G Xiang, S Homma and S Itescu. (2004). Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration. Am J Physiol Heart Circ Physiol 287:H525-H532.
25. Xiang G, MD Schuster, T Seki, AA Kocher, S Eshghi, A Boyle and S Itescu. (2004). Down-regulation of plasminogen activator inhibitor 1 expression promotes myocardial neovascularization by bone marrow progenitors. J Exp Med 200:1657-1666.
26. Iwasaki H, A Kawamoto, M Ishikawa, A Oyamada, S Nakamori, H Nishimura, K Sadamoto, M Horii, T Matsumoto, S Murasawa, T Shibata, S Suehiro and T Asahara. (2006). Dose-dependent contribution of CD34-positive cell transplantation to concurrent vas-culogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113:1311-1325.
27. Brenner W, A Aicher, T Eckey, S Massoudi, M Zuhayra, U Koehl, C Heeschen, WU Kampen, AM Zeiher, S Dimmeler and E Henze. (2004). 111I n-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 45:512-518.
28. Aicher A, W Brenner, M Zuhayra, C Badorff, S Massoudi, B Assmus, T Eckey, E Henze, AM Zeiher and S Dimmeler. (2003). Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107:2134-2139.
29. Kawamoto A, H Iwasaki, K Kusano, T Murayama, A Oyamada, M Silver, C Hulbert, M Gavin, A Hanley, H Ma, M Kearney, V Zak, T Asahara and DW Losordo. (2006). CD34-Positive cells exhibit increased potency and safety for therapeutic neovas-cularization after myocardial infarction compared with total mononuclear cells. Circulation 114:2163-2169.
30. Grinnemo KH, A Mansson, G Dellgren, D Klingberg, E Wardell, V Drvota, C Tammik, J Holgersson, O Ringden, C Sylven and K Le Blanc. (2004). Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 127:1293-1300.
31. Kawamoto A, HC Gwon, H Iwaguro, JI Yamaguchi, S Uchida, H Masuda, M Silver, H Ma, M Kearney, JM Isner and T Asahara. (2001). Therapeutic potential of ex vivo expanded endothe-lial progenitor cells for myocardial ischemia. Circulation 103:634-637.
32. Ott I, U Keller, M Knoedler, KS Gotze, K Doss, P Fischer, K Urlbauer, G Debus, N von Bubnoff, M Rudelius, A Schomig, C Peschel and RA Oostendorp. (2005). Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J 19:992-994.
33. Yoon YS, A Wecker, L Heyd, JS Park, T Tkebuchava, K Kusano, A Hanley, H Scadova, G Qin, DH Cha, KL Johnson, R Aikawa, T Asahara and DW Losordo. (2005). Clonally expanded novel mul-tipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115:326-338.
34. Murasawa S, A Kawamoto, M Horii, S Nakamori and T Asahara. (2005). Niche-dependent translineage commitment of endothe-lial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler Thromb Vasc Biol 25:1388-1394.
35. Kawamoto A, T Tkebuchava, J Yamaguchi, H Nishimura, YS Yoon, C Milliken, S Uchida, O Masuo, H Iwaguro, H Ma, A Hanley, M Silver, M Kearney, DW Losordo, JM Isner and T Asahara. (2003). Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107:461-468.